Bull/Bear Index 47.4/100
→
Ildong Pharmaceutical absorbs R&D subsidiary Yunovia... "Responding to drug price reform, focusing on R&D"
Key takeaway
"Ildong Pharmaceutical absorbs R&D subsidiary Yunovia... "Responding to drug price reform, focusing on R&D"" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 25 out of 100. Reported by Maeil Business on April 13, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 49.2%.
Join Telegram channel
or scan with phone →